Related Experiment Video
Updated: Jun 11, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Association Between Hemoglobin-Creatinine Ratio and Six-Month All-Cause Readmission in Chinese Patients with Heart
Minghang Li1, Xuyang Li1, Zhang Ye2
1The Second College of Clinical Medicine, Chongqing Medical University, Chongqing, China.
Insights
The hemoglobin-creatinine ratio (HBCR) can predict heart failure (HF) readmissions. Lower HBCR levels are linked to a higher risk of HF readmission within six months, suggesting its utility in patient risk stratification.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Heart failure (HF) readmission is a significant global healthcare challenge.
- Anemia (hemoglobin [Hb]) and renal dysfunction (creatinine [Cr]) are known HF risk factors.
- The combined hemoglobin-creatinine ratio (HBCR) as a predictor for HF readmission needs further investigation.
Purpose of the Study:
- To investigate the association between admission HBCR and six-month all-cause readmission in HF patients.
- To determine if HBCR can identify high-risk HF patients for targeted interventions.
Main Methods:
- Retrospective cohort study of 1,833 adult HF survivors.
- HBCR calculated using admission Hb (g/L) and Cr (µmol/L).
- Multivariable analysis adjusted for demographics, comorbidities, and laboratory values.
Main Results:
- 37.6% of patients were readmitted within six months.
- Lower admission HBCR correlated with increased readmission hazard.
- Each SD increase in HBCR independently reduced readmission risk by 20% (aHR=0.80).
- The highest HBCR tertile showed a 41% reduced readmission risk compared to the lowest (aHR=0.59).
Conclusions:
- Admission HBCR is an independent predictor of six-month all-cause readmission in hospitalized HF patients.
- HBCR may aid in identifying high-risk patients prior to discharge.
- Further prospective studies are needed to confirm if HBCR-guided management impacts HF readmission rates.
Background:
Globally, heart failure (HF) readmission presents a significant challenge. Although anemia (reflected by hemoglobin [Hb]) and renal dysfunction (reflected by creatinine [Cr]) are established independent risk factors for poor HF outcomes, the value of their combined ratio called hemoglobin-creatinine ratio (HBCR), specifically for six-month all-cause readmission risk in patients with HF, requires further exploration.
Aims:
This study aimed to investigate the association between admission HBCR and six-month all-cause readmission after HF hospitalization.
Methods:
We conducted a retrospective cohort study of 1,833 adults who survived an initial HF admission. HBCR was calculated by dividing the admission Hb (g/L) by the admission Cr (µmol/L). The primary outcome was six-month all-cause readmission. Multivariable analysis adjusted for demographics, comorbidities, and key labs assessed the independent association.
Results:
Within six months, 689 patients (37.6%) were readmitted. Lower admission HBCR significantly correlated with a higher readmission hazard. After full adjustment, each one standard deviation (SD) increase in HBCR was independently associated with a 20% lower readmission hazard (adjusted hazard ratio [aHR] = 0.80, 95% confidence interval [CI]: 0.71-0.90, p <0.001). This association showed a graded inverse relationship across tertiles: versus the lowest, the highest tertile had a 41% reduced risk (aHR = 0.59, 95% CI: 0.48-0.73, p <0.001).
Conclusion:
Admission HBCR is independently associated with six‑month all‑cause readmission in Chinese patients hospitalized for HF and may help identify patients at higher risk before discharge. Prospective interventional studies and external validation are required to determine whether HBCR‑guided management reduces HF readmissions.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Heart Failure VI: Adjunct Therapies
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...